Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.02.006
Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2018.10.002
Adjuvant Therapy in Patients With Completely Resected Non–small‐cell Lung Cancer: Current Status and Perspectives
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.09.016
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.11.005
Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.07.006
Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2018.12.014
Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.02.008
Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.09.010
Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.06.020
Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.02.005
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.03.004
Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2018.12.003
Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.09.013
Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to Nivolumab.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.08.006
Significance of 18F‐FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non–small‐cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.08.018
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non–small‐cell Lung Cancer at Diagnosis
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.09.014
Monitoring Treatment Response to Erlotinib in EGFR‐mutated Non–small‐cell Lung Cancer Brain Metastases Using Serial O‐(2‐[18F]fluoroethyl)‐L‐tyrosine PET
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.10.011
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.07.009
Identification and Development of a Lung Adenocarcinoma PDX Model With STRN‐ALK Fusion
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.11.002
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.02.013
Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.09.009
Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.09.001
Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.02.021
High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service–Health Screening Cohort
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.11.009
Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.06.008
Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.08.005
EGFR Gene Polymorphism Predicts Improved Outcome in Patients With EGFR Mutation-positive Non-small cell Lung Cancer Treated With Erlotinib.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.02.011
Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2018.12.016
Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.04.003
Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.03.005
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.10.013
Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.06.003
A Phase II Study of Nivolumab in Patients With Advanced Non–small‐cell Lung Cancer who Responded to Prior PD‐1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L)
来源期刊：Clinical Lung CancerDOI：10.1016/j.cllc.2018.12.001
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.11.008
Management of Central Nervous System Metastases in Patients With Advanced Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer During Crizotinib Treatment.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.06.013
Pulmonary Carcinosarcoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.07.001
Development and Validation of a 18F-FDG PET/CT-Based Clinical Prediction Model for Estimating Malignancy in Solid Pulmonary Nodules Based on a Population With High Prevalence of Malignancy.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.07.014
Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.02.017
Association Between Nicotine-dependent Gene Polymorphism and Smoking Cessation in Patients With Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.07.002
Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.04.012
Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.11.014
Spirituality and Emotional Distress Among Lung Cancer Survivors.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.06.015
Survival Disparities in Black Patients With EGFR-mutated Non-small-cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.07.003
Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2018.11.012
Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.11.015
Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.10.010
Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.10.012
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
来源期刊：Clinical lung cancerDOI：10.1016/J.CLLC.2019.06.019
Increased Galectin-1 Expression in Thymic Epithelial Tumors.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2018.12.005
CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non-small-cell Lung Cancer.
来源期刊：Clinical lung cancerDOI：10.1016/j.cllc.2019.08.004
投稿咨询
加急服务
论文发表
2-4个月录用
7500+文章录用
不成功可退款
